[IKT] QoQ Quarter Result on 31-Mar-2024 [#Q1]

Stock
[IKT] Inhibikase Therapeutics, Inc.
Announcement Date
15-May-2024
Financial Year
2024
Quarter
31-Mar-2024 [#Q1]
Profit Trend
QoQ- -11.30%
YoY- -16.16%
Quarter Report
IKT's Result
IKT's Financial Summary
View:
Show?
Quarter Result
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
Revenue 0 0 0 0 80 116 65 -
PBT -5,778 -4,960 -4,650 -4,178 -4,595 -5,778 -4,478 18.46%
Tax 0 0 0 0 46 37 -474 -
NP -5,778 -4,960 -4,650 -4,178 -4,595 -5,778 -4,003 27.63%
Tax Rate - - - - - - - -
Total Cost 5,778 4,960 4,650 4,178 4,675 5,894 4,068 26.27%
Ratio Analysis
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
NP Margin 0.00 0.00 0.00 -417,794,000.00 -5,775.11 -4,963.46 -6,204.86 -
Per Share
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
EPS -0.65 -0.66 -0.73 -0.68 -0.86 -1.11 -0.87 -17.61%
EPS Diluted -0.65 -0.66 -0.73 -0.68 -0.86 -1.11 -0.87 -17.61%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.